To assess the efficacy of a 1064nm picosecond laser (PicoWay; Candela; Marlborough, MA) with diffractive lens array and a picosecond 755nm laser (PicoSure®; Cynosure®; Westford, MA) with diffractive lens array in subjects for the improvement of facial skin quality. Secondary objectives of this clinical trial are to assess whether the 1064nm or 755nm picosecond laser is more efficacious in improving facial skin quality, safety of the procedure, comfortability of the procedure, and subject satisfaction.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Scientific Assessment Scale of Skin Quality (SASSQ) to assess change
Timeframe: Screening, Baseline, Day 28, Day 56, Day 140
Physician Global Aesthetic Improvement Scale (PGAIS) by blinded investigator to assess change
Timeframe: Day 28, Day 56, Day 140
Percent improvement of skin quality by blinded investigator to assess change
Timeframe: Day 28, Day 56, Day 140